Autoinflammatory diseases in dermatology: DITRA and CAMPS

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Autoinflammatory diseases like DITRA and CAMPS are increasingly recognized in dermatology.
• Recent identification of causative genes for DITRA (IL36RN) and CAMPS (CARD14) offers new insights.
• Understanding these genetic underpinnings is crucial for diagnosing and managing related conditions.

Purpose of the Study:

• To explain the causative genes IL36RN for DITRA and CARD14 for CAMPS.
• To describe the clinical features and therapies for generalized pustular psoriasis without psoriasis vulgaris (GPP without PsV).
• To describe the clinical features and therapies for pityriasis rubra pilaris type V (PRP type V), a representative disease of CAMPS.

Main Methods:

• Literature review and synthesis of current research on DITRA and CAMPS.
• Detailed explanation of the roles of IL36RN and CARD14 genes.
• Clinical case descriptions and treatment strategies for GPP without PsV and PRP type V.

Main Results:

• IL36RN deficiency causes DITRA, characterized by conditions like GPP without PsV.
• CARD14 mutations lead to CAMPS, with PRP type V being a key example.
• Specific clinical manifestations and therapeutic approaches for these distinct dermatological conditions were elucidated.

Conclusions:

• IL36RN and CARD14 are the primary genetic drivers of DITRA and CAMPS, respectively.
• GPP without PsV and PRP type V serve as important clinical models for understanding DITRA and CAMPS.
• Further research into these genetic pathways can inform targeted therapies for autoinflammatory dermatoses.